Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
about
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptorsOrganophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoidsSubstrate selectivity of bacterial monoacylglycerol lipase based on crystal structureBiochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibitionActivation of the endocannabinoid system by organophosphorus nerve agents.Refined homology model of monoacylglycerol lipase: toward a selective inhibitor.Highly predictive ligand-based pharmacophore and homology models of ABHD6.Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampusCannabinoids in the management of spasticity associated with multiple sclerosis.Endocannabinoid-mediated control of synaptic transmission.Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.Latest advances in cannabinoid receptor agonists.Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis.The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.Experimental cannabinoid 2 receptor-mediated immune modulation in sepsisModulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase.Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors.Treating a novel plasticity defect rescues episodic memory in Fragile X model mice.Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2 α.ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
P2860
Q24602845-43570EAD-2BF9-4E0B-89F0-14BE8CEE9385Q24658124-6568EA9A-08BB-4A48-B93B-F4C06943AE6FQ27690646-9FEA3099-6BB1-4D75-BDC8-32FD268C6DBEQ28483214-ED7E20B9-0CCF-4D27-8509-7583BA1DA755Q34011342-254087CB-B3DE-4E69-BC84-A570C5D8FE2CQ35841379-06E6747E-D46C-426D-B152-3E814B27464BQ36612107-BCAD2DCF-445E-4C31-9566-90BBF5AF2FF9Q36917918-4D4F0BBB-B420-4C02-8D90-B2BAF5BA34A0Q37062594-42F9D0FC-E273-4F35-A1F3-F6524EDA3495Q37363621-7D3F91AB-5603-402F-A366-040DC5102738Q37593467-805E55AE-03EC-483D-9EE3-60FF8166FAD0Q37638736-B2B523D6-4D29-4C7E-B84B-DF35E3A68DF9Q37679402-06DA9DCA-EC5E-4D9A-B0C0-469CAD279F7EQ37892742-135F6875-1E8F-46DA-8D51-9FCE60A4F526Q38052298-F5ED0FAC-E6AD-4030-809C-80CF012FF23EQ38923749-D231A985-F3D4-4608-8C40-D2D297F86676Q41140010-A3F31D23-ABD0-4BC4-82C0-5B8D2BD42665Q43265581-CC2E7DAF-90BA-497A-A1CF-009B17D40FCAQ45995000-59D222A0-B471-41E7-AF6F-210B57794818Q46229249-BCFB8BEB-E574-4F49-A438-328F95075368Q52767073-C179C820-70F8-4214-83B6-DE0739775287Q52890709-3207D0D3-97D0-49B7-879A-ABF1E9E0D666
P2860
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
@en
type
label
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
@en
prefLabel
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
@en
P2860
P1476
Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors
@en
P2093
Susanna M Saario
P2860
P304
P356
10.1111/J.1742-7843.2007.00130.X
P577
2007-11-01T00:00:00Z